...
首页> 外文期刊>Progress in Artificial Intelligence >Tigecycline Susceptibility of Carbapenem Resistant Enterobacteriaceae and Acinetobacter spp. isolates from Respiratory Tract: ATertiary Care Centre Study
【24h】

Tigecycline Susceptibility of Carbapenem Resistant Enterobacteriaceae and Acinetobacter spp. isolates from Respiratory Tract: ATertiary Care Centre Study

机译:鲤鱼霉素抗肠杆菌和SPP耐药性抗菌菌和SPP的易感性。 呼吸道中的分离物:附带服务中心研究

获取原文
获取原文并翻译 | 示例

摘要

Background: Tigecycline is used as a last line of defence against Multidrug Resistant (MDR) strains, and increasing rates of resistance are a growing concern globally. Tigecycline resistance has been reported in various pathogens including Acinetobacter spp., Klebsiella spp., Enterobacter spp., E. faecalis, S. aureus, S. pneumoniae and Serratia marcescens. Aim and Objectives: To study Tigecycline susceptibility pattern of isolates of Enterobacteriaceae and Acinetobacter spp. from Respiratory Tract Infections (RTI) in a tertiary care hospital. Material and Methods: A total of 7573 respiratory samples were received in Microbiology Department of Govind Ballabh Pant Institute of Postgraduate Medical Education and Research (GIPMER) from 1st January 2018 to 31st December 2018. The samples were processed as per standard techniques. Identification and antimicrobial susceptibility testing was done by VITEK-2 Compact automated system and Kirby - Bauer Disc Diffusion Method as per CLSI Guidelines. Results: Out of total 7573 respiratory samples received in laboratory, 1017 (13.42%) were culture positive for pathogens. Klebsiella pneumoniae 420( 41.29%) was predominantly isolated microorganism followed by Pseudomonas aeruginosa 206( 20.25%) and Acinetobacter spp. 193(18.97%). Most of Gram negative organisms were resistant to commonly used antibiotics. Carbapenem resistance was observed as 67.25%. Conclusion: Overall Tigecycline resistance among Carbapenem Resistant Enterobacteriaceae (CRE) and Carbapenem Resistant Acinetobacter (CRA) was found to be 15.50% and 10.69% respectively. Although Tigecycline is a promising antibiotic for the treatment of infections caused by drug resistant problematic pathogens, Tigecycline resistance is most frequently observed in A. baumannii and Enterobacteriaceae, especially in MDR strains. Hence, we advocate judicious use of Tigecycline in MDR infections and it should be kept as reserve.
机译:背景:Tigeccline被用作对多药抗性(MDR)菌株的最后一系列防御,并且抵抗率的增加是全球日益增长的关注。在各种病原体中报道了替代霉素抗性,包括血管杆菌,Klebsiella spp。,肠杆菌,E. faecalis,S. aureus,S. pneumoniae和Serratia marcescens。目的和目标:研究肠杆菌和SPP分离株的Tigeccline易感模式。从高等教育医院中的呼吸道感染(RTI)。材料和方法:从2018年1月1日至2018年12月31日,在Govind Ballabh Pant研究生研究所(Gover)研究所的微生物科学系中共有7573次呼吸样品。按照标准技术处理样品。根据CLSI指南,Vitek-2紧凑型自动化系统和Kirby - Bauer光盘扩散方法采用鉴定和抗微生物易感性测试。结果:在实验室收到的7573个呼吸样品中,1017(13.42%)是病原体阳性的培养阳性。 Klebsiella Pneumoniae 420(41.29%)主要是孤立的微生物,其次是假单胞菌铜绿假单胞菌206(20.25%)和分枝杆菌。 193(18.97%)。大多数革克阴性生物对常用的抗生素抵抗力。鲤鱼抗性被观察到67.25%。结论:耐肠道肠杆菌(CRE)和碳癌耐药性(CRA)的总体氯丁含量抗性分别为15.50%和10.69%。虽然Tigecycline是一种有希望的抗生素,用于治疗耐药病原体引起的感染,但在A.Baumannii和肠杆菌的植物中最常观察到Tigeccline抗性,特别是在MDR菌株中。因此,我们提倡在MDR感染中的明智使用Tigecycline,并将其保留为储备。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号